missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SARS-CoV-2 Spike Protein RBD Monoclonal Antibody (5G8)
Mouse Monoclonal Antibody
Brand: Invitrogen™ PA5143499
This item is not returnable.
View return policy
Description
SARS-CoV-2 Spike Protein RBD Monoclonal Antibody for Western Blot, ICC/IF, IHC
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold symptoms to severe effects including death and respiratory distress. The CoV Spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Of note is the Spike protein receptor-binding domain (RBD, S-RBD) in SARS-CoV-2 Spike protein which binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. SARS-CoV-2 RBD exhibits significantly higher binding affinity to ACE2 receptor than SARS-CoV RBD in comparison. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.
Specifications
| SARS-CoV-2 Spike Protein RBD | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 50% glycerol and 5mM sodium azide | |
| Mouse | |
| Protein A/G | |
| RUO | |
| Virus | |
| Antibody | |
| IgG1 |
| Immunohistochemistry, Western Blot, Immunocytochemistry | |
| 5G8 | |
| Unconjugated | |
| Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 | |
| Recombinant SARS-CoV2 S-Protein ACE2 binding domain expressed in and purified from E. coli. | |
| 500 μL | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction